Deciphering the EU clinical trials regulation
- 10 March 2016
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (3), 231-233
- https://doi.org/10.1038/nbt.3492
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meetingBMJ Open, 2015
- Genome Editing Technologies: Defining a Path to ClinicMolecular Therapy, 2015
- A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIVTrends in Molecular Medicine, 2014
- Preparing for Responsible Sharing of Clinical Trial DataNew England Journal of Medicine, 2013
- The health of European medical researchEMBO Reports, 2011
- Has the European Clinical Trials Directive been a success?BMJ, 2010
- Virtual screening: an endless staircase?Nature Reviews Drug Discovery, 2010
- Challenges with advanced therapy medicinal products and how to meet themNature Reviews Drug Discovery, 2010
- Ethical and Scientific Implications of the Globalization of Clinical ResearchNew England Journal of Medicine, 2009